John P.A. IoannidisProfessor - Stanford University
John P.A. Ioannidis (b. New York, NY, 1965) holds the C.F. Rehnborg Chair in Disease Prevention at Stanford University, and he is Professor of Medicine, and of Health Research and Policy, and Director of the Stanford Prevention Research Center at the School of Medicine; Professor of Statistics (by courtesy) at the School of Humanities and Sciences; one of the two Directors of the Meta-Research Innovation Center at Stanford; and Director of the PhD program in Epidemiology and Clinical Research. He is a member of the executive board of the Human Genome Epidemiology Network and Senior Advisor on Knowledge Integration at NCI/NIH and has served as President of the Society for Research Synthesis Methodology, as a member of the editorial board of many leading international journals (including PLoS Medicine, Lancet, Annals of Internal Medicine, Journal of the National Cancer Institute, AIDS, International Journal of Epidemiology, Journal of Clinical Epidemiology, Clinical Trials, Cancer Treatment Reviews, Open Medicine, and PLoS ONE, among others) and as Editor-in-Chief of the European Journal of Clinical Investigation (2010-now). He has given over 350 invited and honorary lectures, has received many awards. He has published over 800 papers and is one of the most-cited scientists worldwide according to citation databases for which rankings are available (Web of Science/Highly-Cited Researchers, Scopus, Microsoft Academic Search).
Pedro BomDeusto Business School - University of Deusto
Pedro Bom holds a BSc degree from ISEG/Technical University of Lisbon (2004) and an MPhil degree from Tilburg University (2006). In 2011, he received his PhD from Tilburg University. From 2011 to 2015, he held an assistant professorship at the University of Vienna. He joined the University of Deusto in 2015, where he became a tenured senior lecturer in 2018. Pedro’s research interests lie in the fields of macroeconomics and econometrics. Most of his published work deals with the macroeconomic effects of public capital and, more recently, with the development of meta-analysis methods in economics.